Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 …

…, SJ Sepulveda, J Lövey, H Wheeler, PL Inglis… - The Lancet …, 2017 - thelancet.com
Background Rindopepimut (also known as CDX-110), a vaccine targeting the EGFR deletion
mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet …

[HTML][HTML] A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma

…, S Campbell, C Winter, H Do, A Dobrovic, PL Inglis… - Scientific reports, 2019 - nature.com
Low-passage, serum-free cell lines cultured from patient tumour tissue are the gold-standard
for preclinical studies and cellular investigations of glioblastoma (GBM) biology, yet …

[HTML][HTML] The dystroglycan receptor maintains glioma stem cells in the vascular niche

…, FM Smith, CLR Jurd, T Robertson, PL Inglis… - Acta …, 2019 - Springer
Glioblastomas (GBMs) are malignant central nervous system (CNS) neoplasms with a very
poor prognosis. They display cellular hierarchies containing self-renewing tumourigenic …

[HTML][HTML] Q-Cell glioblastoma resource: proteomics analysis reveals unique cell-states are maintained in 3D culture

…, Y Li, BW Stringer, H Alexander, Z Lwin, PL Inglis… - Cells, 2020 - mdpi.com
Glioblastoma (GBM) is a treatment-refractory central nervous system (CNS) tumour, and better
therapies to treat this aggressive disease are urgently needed. Primary GBM models that …

Management trends and outcomes of pineal germinoma in a multi-institutional Australian cohort

…, T Robertson, T Rajah, Q Tran, P Inglis - Journal of Clinical …, 2021 - Elsevier
Pineal germinoma is rare with high cure rates following craniospinal radiotherapy. Efforts to
reduce the radiotherapy dose and field via combination with chemotherapy suggest …

Adult medulloblastoma in an Australian population

…, J Lynam, C Gzell, JR Whittle, S Cain, P Inglis… - Journal of Clinical …, 2022 - Elsevier
Medulloblastoma in adult patients is a rare condition with limited contemporary demographic
and treatment outcome data available in an Australian population. We conducted a …

Germline ERBB3 mutation in familial non-small-cell lung carcinoma: expanding ErbB's role in oncogenesis

AM McInerney-Leo, HY Chew, PL Inglis… - Human Molecular …, 2021 - academic.oup.com
Lung cancer is the commonest cause of cancer deaths worldwide. Although strongly associated
with smoking, predisposition to lung cancer is also heritable, with multiple common risk …

Phase I safety and bioimaging trial of ifabotuzumab in patients with glioblastoma

H Gan, L Cher, PL Inglis, Z Lwin, E Lau, C Wichmann… - 2021 - Soc Nuclear Med
104 Objectives: Glioblastoma multiforme (GBM) is the most frequent and lethal primary brain
neoplasm, with only 10% of patients surviving 5 years. EphA3 is a tumor restricted antigen …

The Q-IMPROvE (Queensland-IMplementation of PRecision Oncology in brEast cancer) pilot study

…, K Cuff, M Cummings, D Fairbairn, P Inglis… - medRxiv, 2023 - medrxiv.org
Background The cancer genomics field has embraced the advent of precision oncology,
and vast volumes of data have been mined for biomarkers of drug actionability. While some …

[PDF][PDF] Germline ERBB3 mutation in familial non-small cell lung carcinoma: expanding the role of the ErbB family in oncogenesis.

AM McInerney-Leo, HY Chew, PL Inglis, PJ Leo… - academia.edu
Lung cancer is the commonest cause of cancer deaths worldwide. Although strongly
associated with smoking, predisposition to lung cancer is also heritable with multiple …